+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Dihydroavenanthramide D Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6124104
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Dihydroavenanthramide D is gaining traction as a multifaceted bioactive ingredient, driving shifts in both consumer-focused and clinical skincare innovation. This market is evolving with new scientific insights, regulatory scrutiny, and a demand for transparent sourcing in specialty dermatological actives.

Market Snapshot: Dihydroavenanthramide D Market Overview

The Dihydroavenanthramide D market grew from USD 244.30 million in 2025 to USD 262.38 million in 2026. With an expected CAGR of 4.88%, the market is forecast to reach USD 341.10 million by 2032. Growth momentum is supported by advances in formulation technologies, increasing consumer preference for evidence-based actives, and expanding application possibilities across personal care and clinical segments.

Scope & Segmentation

  • Formulation Types: Market participants are actively developing creams, lotions, and serums. Creams further segment into day and night variants, focusing on properties such as sunscreen compatibility or reparative benefits. Lotions target body and hand care, while serums deliver concentrated actives for facial applications.
  • Applications: Dihydroavenanthramide D is used in anti-aging, skin brightening, and sunscreen adjuncts. Its anti-inflammatory and antioxidant properties bridge both cosmetic and clinical efficacy needs.
  • Distribution Channels: Products reach buyers via offline (department stores, specialty stores) and online (brand websites, e-commerce) platforms, each supporting unique marketing and consumer engagement strategies.
  • End-Use Industries: The ingredient supports both the personal care sector, where regulatory requirements prioritize claims substantiation, and pharmaceuticals, where clinical evidence and strict manufacturing controls are essential.
  • Regional Markets: Market adoption is shaped across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Each region presents unique regulatory demands and consumer expectations, impacting product entry, localization, and scaling strategies.
  • Technology Trends: Innovations include advanced extraction, synthetic and biotech production, in vitro validation, delivery system optimization, and stability enhancement. These technologies offer improved efficacy, tolerability, and quality assurance for specialty actives.

Key Takeaways for Decision-Makers

  • The distinctive biochemical profile of dihydroavenanthramide D enables its use in formulations targeting sensitive and reactive skin, with claims rooted in both anti-inflammatory action and reduced irritation potential.
  • Collaboration among ingredient suppliers, contract development organizations, and regulatory consultants is rising, helping brands accelerate time-to-market and navigate complex product substantiation requirements.
  • Consumer demand for transparency and clinically validated actives is driving brands to invest in rigorous analytics and supply chain traceability, affecting both marketing narratives and compliance efforts.
  • Rapidly evolving distribution models, particularly in digital and direct-to-consumer channels, shape both launch velocity and lifecycle management for new formulations containing dihydroavenanthramide D.
  • Market leaders are differentiating by emphasizing sustainable sourcing, proprietary synthesis or fermentation methods, and flexible supply agreements that accommodate regional regulatory dynamics.

Tariff Impact: Navigating 2025 Challenges

  • Tariff changes in 2025 have added new considerations to procurement, compelling brands to reassess supplier diversity, inventory positioning, and contract manufacturing partnerships for specialty skincare actives.
  • Pricing strategies and local processing investments increasingly hinge on detailed cost modeling that factors in tariffs, customs classifications, and administrative timelines.
  • Closer cooperation between buyers and suppliers helps mitigate customs risks through documentation of product origins and compositions, directly influencing time to market and compliance assurance.

Methodology & Data Sources

The research synthesizes insights from expert interviews, peer-reviewed scientific literature, regulatory reviews, and company disclosures. This triangulated approach provides a validated perspective, highlighting both strategic trends and practical issues across the supply chain and market segments.

Why This Report Matters

  • Senior leaders gain actionable insights into segment strategies, partnership models, and regional regulatory frameworks, streamlining go-to-market planning and portfolio differentiation.
  • Risk mitigation is supported with in-depth analysis of tariff impacts and supply chain resilience, aligning procurement agility with commercial objectives.
  • Evidence-driven intelligence sharpens competitive positioning for both ingredient manufacturers and downstream brands, supporting investment and operational decisions.

Conclusion

Dihydroavenanthramide D offers actionable potential in topical skincare innovation where clinical validation, robust supply strategies, and tailored commercialization shape long-term value. This report equips senior decision-makers to anticipate shifts, secure resilient operations, and align product portfolios with emerging quality and transparency benchmarks.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Dihydroavenanthramide D Market, by Form
8.1. Cream
8.1.1. Day Cream
8.1.2. Night Cream
8.2. Lotion
8.2.1. Body Lotion
8.2.2. Hand Lotion
8.3. Serum
9. Dihydroavenanthramide D Market, by Application
9.1. Anti-Aging
9.1.1. Elasticity Improvement
9.1.2. Wrinkle Reduction
9.2. Skin Brightening
9.3. Sunscreen
10. Dihydroavenanthramide D Market, by Distribution Channel
10.1. Offline Retail
10.1.1. Department Stores
10.1.2. Specialty Stores
10.2. Online Retail
10.2.1. Brand Websites
10.2.2. E-Commerce Platforms
11. Dihydroavenanthramide D Market, by End Use Industry
11.1. Personal Care
11.2. Pharmaceuticals
12. Dihydroavenanthramide D Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Dihydroavenanthramide D Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Dihydroavenanthramide D Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Dihydroavenanthramide D Market
16. China Dihydroavenanthramide D Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Ashland Global Holdings Inc
17.6. BASF SE
17.7. Chemicea Limited
17.8. Clariant AG
17.9. Corbion NV
17.10. Croda International Plc
17.11. DSM-Firmenich SA
17.12. Evonik Industries AG
17.13. Givaudan SA
17.14. Lonza Group Ltd
17.15. Symrise AG
17.16. Wuhan BJM Pharm Inc.
List of Figures
FIGURE 1. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DAY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DAY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DAY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY NIGHT CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY NIGHT CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY NIGHT CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY BODY LOTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY BODY LOTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY BODY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY HAND LOTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY HAND LOTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY HAND LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ELASTICITY IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ELASTICITY IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ELASTICITY IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY WRINKLE REDUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY WRINKLE REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY WRINKLE REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SKIN BRIGHTENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SKIN BRIGHTENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SKIN BRIGHTENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SUNSCREEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SUNSCREEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SUNSCREEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DEPARTMENT STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DEPARTMENT STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DEPARTMENT STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY PERSONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY PERSONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 112. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 114. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 115. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 116. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 118. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 120. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 121. EUROPE DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 132. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 134. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 135. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 136. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 138. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 140. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 141. AFRICA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 155. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 156. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 157. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 159. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 161. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 162. ASEAN DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 163. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 165. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 166. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 167. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 169. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 171. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 172. GCC DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 183. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 185. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 186. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 187. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 189. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 190. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 191. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 192. BRICS DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 193. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 195. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 196. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 197. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 199. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 201. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 202. G7 DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 203. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 205. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 206. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 207. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 209. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 211. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 212. NATO DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
TABLE 224. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 225. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 226. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY CREAM, 2018-2032 (USD MILLION)
TABLE 227. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY LOTION, 2018-2032 (USD MILLION)
TABLE 228. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ANTI-AGING, 2018-2032 (USD MILLION)
TABLE 230. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 231. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 232. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
TABLE 233. CHINA DIHYDROAVENANTHRAMIDE D MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Dihydroavenanthramide D market report include:
  • Ashland Global Holdings Inc
  • BASF SE
  • Chemicea Limited
  • Clariant AG
  • Corbion NV
  • Croda International Plc
  • DSM-Firmenich SA
  • Evonik Industries AG
  • Givaudan SA
  • Lonza Group Ltd
  • Symrise AG
  • Wuhan BJM Pharm Inc.

Table Information